Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

General Medicine

Allergy/Immunology

Immune-mediated diseases associated with cancer risks

JAMA | Dec 08, 2021 Allergy/Immunology

Index60 identifies individuals at appreciable risk for stage 3 among an autoantibody-positive population with normal 2-hour glucose levels: Implications for current staging criteria of type 1 diabetes

Diabetes Care | Dec 06, 2021 Allergy/Immunology

Decreased B lymphocytes subpopulations are associated with higher atherosclerotic risk in elderly patients with moderate-to-severe chronic kidney diseases

BMC Nephrology | Dec 06, 2021 Allergy/Immunology

Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: A randomized, double-blind, placebo-controlled, phase 2b dose-finding trial

The Lancet | Dec 05, 2021 Allergy/Immunology

Atopic dermatitis: disease characteristics and comorbidities in smoking and non-smoking patients from the TREATgermany registry

Journal of the European Academy of Dermatology and Venereology | Dec 04, 2021 Allergy/Immunology

Safety and efficacy of interleukin-6-receptor inhibitors in the treatment of neuromyelitis optica spectrum disorders: A meta-analysis

BMC Neurology | Dec 01, 2021 Allergy/Immunology

Salivary free light chains and salivary immunoglobulins as potential non-invasive biomarkers in primary Sjögren's syndrome

International Journal of Rheumatic Diseases | Dec 01, 2021 Allergy/Immunology

Cytokine signature for predicting new-onset prediabetes after acute pancreatitis: A prospective longitudinal cohort study

Cytokine | Nov 26, 2021 Allergy/Immunology

Risk of progression to autoimmune disease in severe drug eruption: Risk factors and the factor-guided stratification

Journal of Investigative Dermatology | Nov 25, 2021 Allergy/Immunology

Parathyroid hormone resistance and autoantibodies to the PTH1 receptor

New England Journal of Medicine | Nov 24, 2021 Allergy/Immunology

« Prev 1 2 3 4 5 6 7 … 76 Next »

Immune-mediated diseases associated with cancer risks

Index60 identifies individuals at appreciable risk for stage 3 among an autoantibody-positive population with normal 2-hour glucose levels: Implications for current staging criteria of type 1 diabetes

Decreased B lymphocytes subpopulations are associated with higher atherosclerotic risk in elderly patients with moderate-to-severe chronic kidney diseases

Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: A randomized, double-blind, placebo-controlled, phase 2b dose-finding trial

Atopic dermatitis: disease characteristics and comorbidities in smoking and non-smoking patients from the TREATgermany registry

Safety and efficacy of interleukin-6-receptor inhibitors in the treatment of neuromyelitis optica spectrum disorders: A meta-analysis

Salivary free light chains and salivary immunoglobulins as potential non-invasive biomarkers in primary Sjögren's syndrome

Cytokine signature for predicting new-onset prediabetes after acute pancreatitis: A prospective longitudinal cohort study

Risk of progression to autoimmune disease in severe drug eruption: Risk factors and the factor-guided stratification

Parathyroid hormone resistance and autoantibodies to the PTH1 receptor

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

These Popular Snacks Linked a Decline in Mental Health

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Anaesthetic Management in Obese Patients

Immune-mediated diseases associated with cancer risks

Index60 identifies individuals at appreciable risk for stage 3 among an autoantibody-positive population with normal 2-hour glucose levels: Implications for current staging criteria of type 1 diabetes

Decreased B lymphocytes subpopulations are associated with higher atherosclerotic risk in elderly patients with moderate-to-severe chronic kidney diseases

Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: A randomized, double-blind, placebo-controlled, phase 2b dose-finding trial

Atopic dermatitis: disease characteristics and comorbidities in smoking and non-smoking patients from the TREATgermany registry

Safety and efficacy of interleukin-6-receptor inhibitors in the treatment of neuromyelitis optica spectrum disorders: A meta-analysis

Salivary free light chains and salivary immunoglobulins as potential non-invasive biomarkers in primary Sjögren's syndrome

Cytokine signature for predicting new-onset prediabetes after acute pancreatitis: A prospective longitudinal cohort study

Risk of progression to autoimmune disease in severe drug eruption: Risk factors and the factor-guided stratification

Parathyroid hormone resistance and autoantibodies to the PTH1 receptor

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

These Popular Snacks Linked a Decline in Mental Health

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Anaesthetic Management in Obese Patients

Select Specialty

Select Topic